Integrichain Blog


340b contract pharmacy

Channel Dave Weiss
January 25, 2024

Transforming Pharmaceutical Trade and Embracing Innovation in Distribution Paradigms

3 Minute Read

Learn about this transformative period which poses both challenges and opportunities, urging stakeholders to adapt and innovate.

Pharmaceutical distribution channel analytics

Channel Dave Weiss
January 10, 2023

Direct Selling as a Distribution Channel for Specialty Lite Pharmaceuticals

3 Minute Read

Insights into specialty lite challenges and a new channel strategy that has emerged to help manufacturers balance patient access with their gross-to-net.

Channel Samer Allabadi
July 13, 2022

Top Trends in Specialty Network and Service Design

5 Minute Read

Benchmarks on specialty networks using our exclusive ICyte channel and patient access data: what specialty networks look like, who's included, and how network sizes vary by therapeutic category.

Channel Aaron Light Umber Afshan
January 13, 2022

Frequently Asked Questions: Channel and Revenue Leakage

3 Minute Read

We discuss how life sciences manufacturers can maximize profit by reducing revenue leakage through actionable channel data insights.

Channel Olivia Nweze Tim Keys
December 20, 2021

Retail Pharmacy’s Digital Transformation

3 Minute Read

As society shifts toward digital and delivery-based economies, we ask: what will pharmacies look like in the future?

Channel Haley Morgaylo
September 24, 2021

Refined Channel Data: Inventory Analytics

3 Minute Read

How IntegriChain’s Inventory Analytics helps manufacturers conquer the complexity of inventory estimation.

340b contract pharmacy

Channel Chris Jewell
August 23, 2021

Refined Channel Data: Unblinding

3 Minute Read

Unblinding national datasets gives Life Sciences manufacturers a clear view into where and when their therapies are being utilized.

Channel Shivani Patel
August 20, 2018

Opioid Crisis Exposes Vulnerabilities in Suspicious Order Monitoring

4 Minute Read

The American opioid crisis exposed gaps in the reporting systems designed to flag suspicious orders of pharmaceutical products classified as controlled substances. Pharmaceutical manufacturers are now facing increased scrutiny...

adapt analytics bars bell books magnify chart connections marker meds pills search computer paper webcast article blog ebook distribute hand payer heart market Asset 69 Asset 65 Asset 64 Asset 68 Asset 67 Asset 66 Asset 63 decrease expand builder close dart data demand increase index lock locked meter open order pharma pill plot prescription revenue scorecard service shake unlocked Asset 61 Asset 60 Asset 71 icon-distribution-distribution-contract-management icon-distribution-distribution-data-refinery icon-distribution-inventory-analytics icon-distribution-retail-analytics icon-patient-patient-data-refinery icon-patient-patient-services-analytics icon-patient-specialty-pharmacy-analytics icon-payer-340b-analytics icon-payer-analytics icon-payer-g2n icon-payer-government-pricing icon-payer-rebate-management Asset 1 hand hand hand hand hand hand hand hand hand hand hand paper article